Skip to content
Stop using now Drug recall · FDA · Published January 23, 2015

Hospira Recalls Ketorolac Tromethamine Injections Due to Crystallization

Hospira Inc. recalls specific lots of Ketorolac Tromethamine Injection due to crystallization. Check lot numbers and expiration dates immediately.

🇺🇸 FDA recall #D-0483-2015DrugHospira ›
Take action

Contact the company

Recalling firmHospira Inc.275 N Field Dr · Lake Forest, IL 60045-2579
✎ GovInfoNow plain-language explainer

What happened, in plain English

Hospira Inc. is recalling KETOROLAC Tromethamine Inj., USP, 60 mg (30 mg/mL), 2 mL Fill Single-dose Vials because the drug has crystallized. This recall affects vials distributed nationwide in the U.S. as well as internationally to Guam and Singapore. The record does not specify a remedy or return process. Read more at govinfonow.com/recall/45018-hospira-inc-recalls-ketorolac-tromethamine-inj-usp-60-mg-30.

Source Summary by GovInfoNow · govinfonow.com/recall/45018-hospira-inc-recalls-ketorolac-tromethamine-inj-usp-60-mg-30 · Updated October 12, 2026 · FDA enforcement record: FDA #D-0483-2015

Cite this page

“Hospira Recalls Ketorolac Tromethamine Injections Due to Crystallization.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/45018-hospira-inc-recalls-ketorolac-tromethamine-inj-usp-60-mg-30. Based on FDA recall #D-0483-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0483-2015%22&limit=1).

Why it’s dangerous

The hazard is crystallization within the single-dose vials. Crystallized medication can pose serious risks if injected, such as blockage of blood vessels or unpredictable drug delivery, although the specific injury mechanism is not detailed in this record.

Who’s affected

Patients and healthcare providers who have received or administered KETOROLAC Tromethamine Injection from the specific lots listed in the record. Individuals using these vials for intravenous (I.V.) or intramuscular (I.M.) use are at risk.

How to tell if you have this one

Look for KETOROLAC Tromethamine Inj., USP, 60 mg (30 mg/mL), 2 mL Fill Single-dose Vials manufactured by Hospira, Inc. or labeled under NOVAPLUS. Check the NDC numbers (0409-3796-01 or 0409-3796-49) and specific lot numbers such as 26-098-DK, 29-239-DK, 34-540-DK, 37-037-DK, 41-282-DK, 44-076-DK, 45-240-DK, 46-306-DK, and 26-097-DK against their expiration dates.

  • Brand
    Hospira
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    U.S. Nationwide and International: Guam and Singapore.
Recall numberProduct, codes & lotsQuantityNDC
D-0482-2015KETOROLAC Tromethamine Inj., USP, 30 mg (30 mg/mL), 1 mL Fill, Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-3795-01 --- Also labeled under NOVAPLUS label NDC 0409-3795-49; NDC 0409-3795-01, Lot number: 25-047-DK, 25-048-DK, Exp 1JAN2015; Lot number 26-151-DK, Exp. Date:1FEB2015; Lot number: 28-059-DK, 28-071-DK, 28-072-DK, 28-479-DK, 28-480-DK, Exp. Date:1APR2015; Lot number: 29-556-DK, 29-557-DK, Exp. Date:1MAY2015; Lot number: 35-232-DK, 35-233-DK, 35-234-DK, 35-501-DK, Exp. Date:1NOV2015; Lot number: 36-341-DK, 36-342-DK, 36-343-DK, 36-353-DK, 36-429-DK, 36-430-DK, Exp. Date:1DEC2015; Lot number: 37-141-DK, 37-142-DK, 37-144-DK, 37-145-DK, 37-353-DK, Exp. Date:1JAN2016; Lot number: 38-141-DK, 38-143-DK, Exp. Date:1FEB2016; Lot number: 39-014-DK, 39-104-DK, Exp. Date:1MAR2016; Lot number: 40-301-DK, 40-536-DK, 40-537-DK, 40-544-DK, 40-548-DK, Exp. Date:1APR2016; Lot number: 41-078-DK, Exp. Date:1MAY2016; Lot number: 42-207-DK, 42-253-DK, Exp. Date:1JUN2016; Lot number: 45-358-DK, 45-359-DK, Exp. Date:1SEP2016; Lot number: 46-043-DK, 46-044-DK, 46-047-DK, Exp. Date:1OCT2016 AND NOVAPLUS LABEL NDC 0409-3795-49, Lot number: 27-101-DK, Exp. Date:1MAR2015; Lot number: 35-229-DK, Exp. Date:1NOV2015; Lot number: 36-217-DK, 36-218-DK, Exp. Date:1DEC2015 and Lot number: 40-534-DK, Exp. Date:1APR2016HOSPIRA = 13,720,475 vials, NOVAPLUS = 1,528,500 vials0409-3793-19, 0409-3793-01, 0409-3793-25, 0409-3795-19, 0409-3795-01, 0409-3795-25, 0409-3796-19, 0409-3796-01, 0409-3796-25, 0409-3795-49
D-0483-2015KETOROLAC Tromethamine Inj., USP, 60 mg (30 mg/mL), 2 mL Fill Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-3796-01 ---- ALSO labeled under NOVAPLUS label NDC 0409-3796-49; NDC 0409-3796-01, Lot number: 26-098-DK, Exp. Date:1FEB2015; Lot number: 29-239-DK, 29-240-DK, Exp. Date:1MAY2015; Lot number: 34-540-DK, Exp. Date:1OCT2015; Lot number: 37-037-DK, 37-038-DK, 37-147-DK, 37-148-DK, 37-228-DK, 37-282-DK, Exp. Date:1JAN2016; Lot number: 41-282-DK, 41-284-DK, Exp. Date:1MAY2016; Lot number: 44-076-DK, Exp. Date:1AUG2016; Lot number: 45-240-DK, Exp. Date:1SEP2016 and Lot number: 46-306-DK, Exp. Date:1OCT2016 AND NOVAPLUS label NDC 0409-3796-49, Lot number: 26-097-DK, Exp. Date:1FEB2015.HOSPIRA = 4,339,500 vials. NOVAPLUS = 341,100 vials0409-3793-19, 0409-3793-01, 0409-3793-25, 0409-3795-19, 0409-3795-01, 0409-3795-25, 0409-3796-19, 0409-3796-01, 0409-3796-25, 0409-3796-49
Based on the official FDA remedy

What to do — step by step

  1. Verify Lot Numbers

    Check the NDC numbers (0409-3796-01 or 0409-3796-49) and lot numbers on your vials against the recalled list.

  2. Stop Using Affected Vials

    Do not use any vials that match the recalled lot numbers due to the risk of crystallization.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “U.S. Nationwide and International: Guam and Singapore.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA terminated this recall 12 months after the firm started it.

1. Firm started the recall: Jan 23, 201512. FDA classified it Class II: Apr 8, 201523. Published in FDA’s Enforcement Report: Apr 15, 201534. FDA terminated the recall: Feb 4, 2016420152016
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Which lot numbers are affected?

Affected lots include 26-098-DK, 29-239-DK, 29-240-DK, 34-540-DK, 37-037-DK, 37-038-DK, 37-147-DK, 37-148-DK, 37-228-DK, 37-282-DK, 41-282-DK, 41-284-DK, 44-076-DK, 45-240-DK, 46-306-DK, and 26-097-DK.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0483-2015 (January 23, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0483-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA